Arca
Skip to content
Tools
Tools

70S ribosome

Protein nucleic-acid complex in Streptococcus pneumoniae that 2 drugs act on.

  • Drugs that act on it: 2
  • Approved: 2
  • In phases 1 to 3: 0
  • Sponsors: 1
  • Genes: 55

Who is on it, and how far along

Every drug ChEMBL records acting on RPLA, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 2

Approved2

  • Lincomycin
  • Troleandomycin

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        LincomycinBoxed warningApprovedPfizerSmall moleculeInhibitor70S ribosome inhibitor26
        TroleandomycinApprovedPfizerSmall moleculeInhibitor70S ribosome inhibitor0

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Comparing Nadifloxacin Plus Tretinoin Versus Clindamycin Plus Tretinoin Creams for Mild-to-Moderate AcneLincomycinPhase 4RecruitingNishtar Medical UniversityNov 4, 2026
        Comparison of Amoxicillin, Clindamycin and Azithromycin Single Doses Antibiotic Prophylaxis in Patient Undergoing Lower Third Molar ExtractionLincomycinPhase 4RecruitingDow University of Health SciencesOct 26, 2026
        Clascoterone Versus Clindamycin Added to Adapalene/Benzoyl Peroxide for Moderate Facial AcneLincomycinPhase 4Not yet recruitingAllied Hospital FaisalabadOct 19, 2026
        Moxifloxacin Versus Clindamycin in the Management of Odontogenic Maxillofacial Infectious ProcessesLincomycinNot applicableNot yet recruitingNishtar Medical UniversitySep 9, 2026
        Extended Oral Antibiotic Prophylaxis in Diabetic Fracture PatientsLincomycinPhase 4RecruitingTexas Tech University Health Sciences Center, El PasoMay 1, 2026
        Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives)LincomycinPhase 4Not yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health CentreJan 21, 2026
        Clindamycin as an Alternative to Vancomycin in Patients Undergoing Aortic Cardiac Surgery With Extracorporeal Circulation (ECC)LincomycinPhase 2RecruitingNantes University HospitalDec 5, 2025
        Laparoscopic Antibiotic Lavage to Prevent Intra-abdominal Abscess Formation in Complicated AppendicitisLincomycinPhase 3RecruitingSpaarne GasthuisFeb 21, 2025

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2363853, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.